3+ same-day same-side Form 4 filers WWB

WWB Cluster buy: Otello Stampacchia and two others report purchases

Windward Bio (WWB) filings list purchases worth $29.75 million by Otello Stampacchia and $20,000,007 each by ORBIMED ADVISORS LLC and David P. Bonita.

Transaction Value:
$69,750,014.00
Shares transacted:
4,102,942
Average price:
$17.00
Insider:

Three Form 4 filings report insiders' stock purchases dated November 16, 2026. These reports were filed with the SEC on November 18.

At Windward Bio Group AG (WWB), Otello Stampacchia is listed as a director. ORBIMED ADVISORS LLC and David P. Bonita are each listed as a director and 10% owner. The three filings cover three distinct insiders.

Transaction details

Transaction
Date of Earliest Transaction2026-11-162026-11-162026-11-16
Date of Latest Transaction2026-11-162026-11-162026-11-16
Buy/Sellbuybuybuy
Transaction Count211
Shares Transacted1,750,0001,176,4711,176,471
Price$17.00$17.00$17.00
Total Transaction Value$29,750,000.00$20,000,007.00$20,000,007.00
Insider
Ticker SymbolWWBWWBWWB
CompanyWINDWARD BIO GROUP AGWINDWARD BIO GROUP AGWINDWARD BIO GROUP AG
Insider NameStampacchia OtelloORBIMED ADVISORS LLCBonita David P
Insider TitleDirectorDirector, 10% OwnerDirector, 10% Owner
Sector - IndustryOther - UnclassifiedOther - UnclassifiedOther - Unclassified
Holdings
Total Shares Owned After Transaction875,0001,708,1031,708,103
Position Size Change200.00%68.88%68.88%
Filing
Filing Date2026-11-182026-11-182026-11-18
SEC LinkView filingView filingView filing
Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellbuy
Transaction Count2
Shares Transacted1,750,000
Price$17.00
Total Transaction Value$29,750,000.00
Insider
Ticker SymbolWWB
CompanyWINDWARD BIO GROUP AG
Insider NameStampacchia Otello
Insider TitleDirector
Sector - IndustryOther - Unclassified
Holdings
Total Shares Owned After Transaction875,000
Position Size Change200.00%
Filing
Filing Date2026-11-18
SEC LinkView filing
Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellbuy
Transaction Count1
Shares Transacted1,176,471
Price$17.00
Total Transaction Value$20,000,007.00
Insider
Ticker SymbolWWB
CompanyWINDWARD BIO GROUP AG
Insider NameORBIMED ADVISORS LLC
Insider TitleDirector, 10% Owner
Sector - IndustryOther - Unclassified
Holdings
Total Shares Owned After Transaction1,708,103
Position Size Change68.88%
Filing
Filing Date2026-11-18
SEC LinkView filing
Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellbuy
Transaction Count1
Shares Transacted1,176,471
Price$17.00
Total Transaction Value$20,000,007.00
Insider
Ticker SymbolWWB
CompanyWINDWARD BIO GROUP AG
Insider NameBonita David P
Insider TitleDirector, 10% Owner
Sector - IndustryOther - Unclassified
Holdings
Total Shares Owned After Transaction1,708,103
Position Size Change68.88%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

All three filings list share purchases under transaction code P. Otello Stampacchia reported two transactions. ORBIMED ADVISORS LLC and David P. Bonita each reported one.

What was the average price of the transaction?

The reported average price was $17.00 per share for each of the three insiders.

How did this transaction affect the insider's holdings?

Otello Stampacchia reported buying 1,750,000 shares, with 875,000 shares owned afterward. The purchases equal 200.00% of that reported balance. The available details do not explain why the purchase total exceeds the shares reported afterward.

ORBIMED ADVISORS LLC and David P. Bonita each reported buying 1,176,471 shares and owning 1,708,103 shares afterward. For each, the purchase accounts for 68.88% of the shares reported afterward.

What's the total transaction value?

Otello Stampacchia's two transactions total $29,750,000.00. ORBIMED ADVISORS LLC and David P. Bonita each reported $20,000,007.00. A combined total for separate purchases cannot be confirmed because the available details do not show whether the matching reports cover the same shares.

Are there any special circumstances around this transaction?

The available transaction information did not identify a special arrangement for any of the three insiders. Footnote text was not available, so other terms or circumstances remain unknown.

SEC sources: Filing 1, Filing 2, Filing 3.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.